|
[Related PubMed/MEDLINE]
Total Number of Papers: 4608
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: EGCG |
| Long Form |
: epigallocatechin gallate |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2021 |
Dual effects of ascorbic acid on the stability of EGCG by the oxidation product dehydroascorbic acid promoting the oxidation and inhibiting the hydrolysis pathway. |
AA, DHAA |
| 2 |
2020 |
(-)-Epigallocatechin gallate inhibits stemness and tumourigenicity stimulated by AXL receptor tyrosine kinase in human lung cancer cells. |
GTE |
| 3 |
2020 |
(-)-Epigallocatechin Gallate Promotes MicroRNA 145 Expression against Myocardial Hypoxic Injury through Dab2/Wnt3a/beta-catenin. |
Dab2, MI, miR-145 |
| 4 |
2020 |
(-)-Epigallocatechin gallate-loaded polycaprolactone scaffolds fabricated using a 3D integrated moulding method alleviate immune stress and induce neurogenesis. |
PCL, RSCs, RSMCs |
| 5 |
2020 |
(-)-Epigallocatechin-3-gallate (EGCG) attenuates salt-induced hypertension and renal injury in Dahl salt-sensitive rats. |
--- |
| 6 |
2020 |
(-)-Epigallocatechin-3-gallate induces interferon-lamda2 expression to anti-influenza A virus in human bronchial epithelial cells (BEAS-2B) through p38 MAPK signaling pathway. |
IAV, IFN, NP, p-ERK, p-JNK, pp38 MAPK, qRT-PCR |
| 7 |
2020 |
(-)-Epigallocatechin-3-Gallate Inhibits eNOS Uncoupling and Alleviates High Glucose-Induced Dysfunction and Apoptosis of Human Umbilical Vein Endothelial Cells by PI3K/AKT/eNOS Pathway. |
HG, HUVECs |
| 8 |
2020 |
(-)-Epigallocatechin-3-gallate provides neuroprotection via AMPK activation against traumatic brain injury in a mouse model. |
CCI, TBI |
| 9 |
2020 |
A glucotolerant beta-glucosidase from the fungus Talaromyces amestolkiae and its conversion into a glycosynthase for glycosylation of phenolic compounds. |
--- |
| 10 |
2020 |
A Metal-Polyphenol-Coordinated Nanomedicine for Synergistic Cascade Cancer Chemotherapy and Chemodynamic Therapy. |
CDT |
| 11 |
2020 |
A new epigallocatechin gallate derivative isolated from Anhua dark tea sensitizes the chemosensitivity of gefitinib via the suppression of PI3K/mTOR and epithelial-mesenchymal transition. |
EMT |
| 12 |
2020 |
A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome. |
CT, FXS |
| 13 |
2020 |
A predictive model for astringency based on in vitro interactions between salivary proteins and (-)-Epigallocatechin gallate. |
--- |
| 14 |
2020 |
A prodrug of epigallocatechin-3-gallate alleviates high glucose-induced pro-angiogenic factor production by inhibiting the ROS/TXNIP/NLRP3 inflammasome axis in retinal Muller cells. |
DR, HGF, NLRP3, pro-EGCG, ROS, TXNIP, VEGF |
| 15 |
2020 |
A review for physiological activities of EGCG and the role in improving fertility in humans/mammals. |
CAT, GPx, SOD1, SOD2 |
| 16 |
2020 |
A Simple, Label-Free, and High-Throughput Method to Evaluate the Epigallocatechin-3-Gallate Impact in Plasma Molecular Profile. |
--- |
| 17 |
2020 |
Activation of Myosin Phosphatase by Epigallocatechin-Gallate Sensitizes THP-1 Leukemic Cells to Daunorubicin. |
DNR, MP, MYPT1, MYPT1pT696, PP1, pRb |
| 18 |
2020 |
Acute Epigallocatechin-3-Gallate Supplementation Alters Postprandial Lipids after a Fast-Food Meal in Healthy Young Women: A Randomized, Double-Blind, Placebo-Controlled Crossover Study. |
HDL-C, iAUC |
| 19 |
2020 |
Adducts Derived from (-)-Epigallocatechin Gallate-Amadori Rearrangement Products in Aqueous Reaction Systems: Characterization, Formation, and Thermolysis. |
DP, NMR, TOF |
| 20 |
2020 |
Aldose Reductase Differential Inhibitors in Green Tea. |
EGC, GA, HNE |
| 21 |
2020 |
Amyloid Aggregation of Insulin: An Interaction Study of Green Tea Constituents. |
CF, EC, GA |
| 22 |
2020 |
An online dual-enzyme co-immobilized microreactor based on capillary electrophoresis for enzyme kinetics assays and screening of dual-target inhibitors against thrombin and factor Xa. |
CE, PDA/GO |
| 23 |
2020 |
Analysis of Cadmium, Epigallocatechin Gallate, and Vitamin C Co-exposure on PC12 Cellular Mechanisms. |
Cd |
| 24 |
2020 |
Analysis of inhibitory interaction between epigallocatechin gallate and alpha-glucosidase: A spectroscopy and molecular simulation study. |
--- |
| 25 |
2020 |
Anti-Angiogenic Effects of Phytochemicals on miRNA Regulating Breast Cancer Progression. |
EC, HIF-1alpha, TNBCs |
| 26 |
2020 |
Anti-Cancer Effects of Green Tea Epigallocatchin-3-Gallate and Coffee Chlorogenic Acid. |
CGA |
| 27 |
2020 |
Anti-melanogenic effects of epigallocatechin-3-gallate (EGCG), epicatechin-3-gallate (ECG) and gallocatechin-3-gallate (GCG) via down-regulation of cAMP/CREB /MITF signaling pathway in B16F10 melanoma cells. |
AT, ECG, GCG |
| 28 |
2020 |
Anticancer effects of epigallocatechin-3-gallate nanoemulsion on lung cancer cells through the activation of AMP-activated protein kinase signaling pathway. |
AMPK, MMP, MTT |
| 29 |
2020 |
Antimicrobial Activity of, and Cellular Pathways Targeted by, p-Anisaldehyde and Epigallocatechin Gallate in the Opportunistic Human Pathogen Pseudomonas aeruginosa. |
EOs, PANDAs |
| 30 |
2020 |
Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review. |
TF3 |
| 31 |
2020 |
Antiviral Effect of Epigallocatechin Gallate via Impairing Porcine Circovirus Type 2 Attachment to Host Cell Receptor. |
PCV2 |
| 32 |
2020 |
Anti‑glycolipid disorder effect of epigallocatechin‑3‑gallate on high‑fat diet and STZ‑induced T2DM in mice. |
T2DM |
| 33 |
2020 |
Application of green tea extracts epigallocatechin-3-gallate in dental materials: Recent progress and perspectives. |
--- |
| 34 |
2020 |
Applications of a Standardized Green Tea Catechin Preparation for Viral Warts and Human Papilloma Virus-Related and Unrelated Cancers. |
GTC, HPV, PSV |
| 35 |
2020 |
Assessing the analgesic efficacy of oral epigallocatechin-3-gallate on epidural catheter analgesia in patients after surgical stabilisation of multiple rib fractures: a prospective double-blind, placebo-controlled clinical trial. |
IS, MRF, SSRF |
| 36 |
2020 |
Assessment Synergistic Effects of Integrated Therapy with Epigallocatechin-3-Gallate (EGCG) & Arsenic Trioxide and Irradiation on Breast Cancer Cell Line. |
ATO |
| 37 |
2020 |
Augmentation of Bone Regeneration by Depletion of Stress-Induced Senescent Cells Using Catechin and Senolytics. |
LPS, SIPS, SIPS cells |
| 38 |
2020 |
Author Correction: (-)-Epigallocatechin-3-gallate (EGCG) attenuates salt-induced hypertension and renal injury in Dahl salt-sensitive rats. |
--- |
| 39 |
2020 |
Avenanthramide-C prevents amyloid formation of bovine serum albumin. |
Avn-C, BSA |
| 40 |
2020 |
Beneficial effects of green tea on age related diseases. |
ECG, MetS |
| 41 |
2020 |
Beneficial impact of epigallocatechingallate on LDL-C through PCSK9/LDLR pathway by blocking HNF1alpha and activating FoxO3a. |
ATAC-seq, FOXO, HFD, HNF-1alpha, LDL-C, LDLR, PCSK9 |
| 42 |
2020 |
Bio-transformation of green tea infusion with tannase and its improvement on adipocyte metabolism. |
EGC, GA, GT, TANs |
| 43 |
2020 |
Bioavailability of Epigallocatechin Gallate Administered With Different Nutritional Strategies in Healthy Volunteers. |
FontUp |
| 44 |
2020 |
Biophysical Characterization of Epigallocatechin-3-Gallate Effect on the Cardiac Sodium Channel Nav1.5. |
MD |
| 45 |
2020 |
Bisphenol A(BPA), BPS and BPB-induced oxidative stress and apoptosis mediated by mitochondria in human neuroblastoma cell lines. |
BPA, BPB, BPS, MDA, MMP, SOD |
| 46 |
2020 |
Blockade of RANKL/RANK signaling pathway by epigallocatechin gallate alleviates mast cell-mediated inflammatory reactions. |
IL, MAP, NF, RANKL, TSLP |
| 47 |
2020 |
Brain-targeted co-delivery of beta-amyloid converting enzyme 1 shRNA and epigallocatechin-3-gallate by multifunctional nanocarriers for Alzheimer's disease treatment. |
AD, APP, MWM, NPs, REGS-PN |
| 48 |
2020 |
Broccoli byproducts for protection and co-delivery of EGCG and tuna oil. |
BBP, IP, TO |
| 49 |
2020 |
Calorimetric approach for comparison of Angiopoietin-like protein 4 with other pancreatic lipase inhibitors. |
ANGPTL4, EPL, ITC, LPL, PNLIP |
| 50 |
2020 |
Cancer cell selective probe by mimicking EGCG. |
Akt, cGMP |
| 51 |
2020 |
Catechin profile and hypolipidemic activity of Morinda citrifolia leaf water extract. |
CG, CVDs, EGC, MCL |
| 52 |
2020 |
Catechin-Based Dentin Pretreatment on the Clinical Performance of a Universal Adhesive: A Two-Year Randomized Clinical Trial. |
NCCLs |
| 53 |
2020 |
Catechins reduce inflammation in lipopolysaccharide-stimulated dental pulp cells by inhibiting activation of the NF-kappaB pathway. |
ECG, hDPCs, IL, NF-kappaB, qPCR, TNF |
| 54 |
2020 |
Changes in Tea Plant Secondary Metabolite Profiles as a Function of Leafhopper Density and Damage. |
--- |
| 55 |
2020 |
Characterization of Cistus incanus L. and Cistus ladanifer L. Extracts as Potential Multifunctional Antioxidant Ingredients for Skin Protecting Cosmetics. |
--- |
| 56 |
2020 |
Coencapsulation and Stability Evaluation of Hydrophilic and Hydrophobic Bioactive Compounds in a Cagelike Phytoferritin. |
--- |
| 57 |
2020 |
Colorimetric Differentiation of Flavonoids Based on Effective Reactivation of Acetylcholinesterase Induced by Different Affnities between Flavonoids and Metal Ions. |
AcCh, AcChE, Fla, GC, MH, Pu, rN |
| 58 |
2020 |
Combined effect of (-)-epigallocatechin-3-gallate and all-trans retinoic acid in FLT3-mutated cell lines. |
ATRA |
| 59 |
2020 |
Comparative Kinetics of Acetyl- and Butyryl-Cholinesterase Inhibition by Green Tea Catechins|Relevance to the Symptomatic Treatment of Alzheimer's Disease. |
AChE, AD, BuChE, ECG, EGC |
| 60 |
2020 |
Conformational Insight on WT- and Mutated-EGFR Receptor Activation and Inhibition by Epigallocatechin-3-Gallate: Over a Rational Basis for the Design of Selective Non-Small-Cell Lung Anticancer Agents. |
EGFR, ERL, L858R, MD, NSCLC, TKD, TKI |
| 61 |
2020 |
Control of Reactive Oxygen Species for the Prevention of Parkinson's Disease: The Possible Application of Flavonoids. |
GSK-3beta, Nrf2, PD, ROS |
| 62 |
2020 |
Controlled release and antioxidant activity of chitosan and beta-lactoglobulin complex nanoparticles loaded with epigallocatechin gallate. |
beta-LG, CAA, EE, EGCG-CS NPs, TEM |
| 63 |
2020 |
Could applying gels containing chlorhexidine, epigallocatechin-3-gallate, or proanthocyanidin to control tooth wear progression improve bond strength to eroded dentin? |
CHX, PAC |
| 64 |
2020 |
Current shreds of evidence on the anticancer role of EGCG in triple negative breast cancer: an update of the current state of knowledge. |
ER, HER2, PR, TNBC |
| 65 |
2020 |
Dehydroascorbic Acid Affects the Stability of Catechins by Forming Conjunctions. |
AA, DHAA, EC, ECG, EGC |
| 66 |
2020 |
Dietary Epigallocatechin-3-Gallate Alters the Gut Microbiota of Obese Diabetic db/db Mice: Lactobacillus Is a Putative Target. |
LDL, T2DM |
| 67 |
2020 |
Dietary Phenolics against Breast Cancer. A Critical Evidence-Based Review and Future Perspectives. |
BC, RSV |
| 68 |
2020 |
Dietary supplement of Yunkang 10 green tea and treadmill exercise ameliorate high fat diet induced metabolic syndrome of C57BL/6 J mice. |
EX, HFD, HPLC, IkBalpha, LFD, MetS, NF-kB, TC, TG |
| 69 |
2020 |
Difference in the antibacterial action of epigallocatechin gallate and theaflavin 3,3'-di-O-gallate on Bacillus coagulans. |
TFDG |
| 70 |
2020 |
Differential Cytotoxicity of Rooibos and Green Tea Extracts against Primary Rat Hepatocytes and Human Liver and Colon Cancer Cells - Causal Role of Major Flavonoids. |
GRE, GT, PH |
| 71 |
2020 |
Dipeptidyl Peptidase-4 Is a Target Protein of Epigallocatechin-3-Gallate. |
DPP4 |
| 72 |
2020 |
Disintegration and Dissolution Testing of Green Tea Dietary Supplements: Application and Evaluation of United States Pharmacopeial Standards. |
DSs, USP |
| 73 |
2020 |
Distinct variation in taste quality of Congou black tea during a single spring season. |
ECG, GA, HJC, PCA, TAA, TC, TP |
| 74 |
2020 |
Distinguishing the Effect on the Rate and Yield of Abeta42 Aggregation by Green Tea Polyphenol EGCG. |
--- |
| 75 |
2020 |
Divergent Roles of Kupffer Cell TLR2/3 Signaling in Alcoholic Liver Disease and the Protective Role of EGCG. |
ALD, BMT, TLR2 |
| 76 |
2020 |
Does Green Tea Induce Hormesis? |
--- |
| 77 |
2020 |
Drug-based magnetic imprinted nanoparticles: Enhanced lysozyme amyloid fibrils cleansing and anti-amyloid fibrils toxicity. |
CD, ThT |
| 78 |
2020 |
Duo of (-)-epigallocatechin-3-gallate and doxorubicin loaded by polydopamine coating ZIF-8 in the regulation of autophagy for chemo-photothermal synergistic therapy. |
DOX, NIR, PDA |
| 79 |
2020 |
Durability of resin on bleached dentin treated with antioxidant solutions or lasers. |
AFM |
| 80 |
2020 |
Effect of (-)-Epigallocatechin Gallate to Staphylococcal Enterotoxin A on Toxin Activity. |
IFN-gamma, SEA |
| 81 |
2020 |
Effect of EGCG-gelatin biofilm on the quality and microbial composition of tilapia fillets during chilled storage. |
--- |
| 82 |
2020 |
Effect of epigallocatechin gallate on gene expression of Staphylococcus aureus. |
qPCR |
| 83 |
2020 |
Effect of epigallocatechin gallate on the body composition and lipid profile of down syndrome individuals: Implications for clinical management. |
AMD, BMI, DS |
| 84 |
2020 |
Effect of epigallocatechin-3-gallate (EGCG) on embryos inseminated with oxidative stress-induced DNA damage sperm. |
ATM, ROS |
| 85 |
2020 |
Effect of Green Tea and (-)-Epigallocatechin Gallate on the Pharmacokinetics of Rosuvastatin. |
GTE |
| 86 |
2020 |
Effect of non-covalent and covalent complexation of (-)-epigallocatechin gallate with soybean protein isolate on protein structure and in vitro digestion characteristics. |
SPI |
| 87 |
2020 |
Effects of covalent modification with epigallocatechin-3-gallate on oleosin structure and ability to stabilize artificial oil body emulsions. |
AOB, OL, PC |
| 88 |
2020 |
Effects of different ultrasound frequencies on the structure, rheological and functional properties of myosin: Significance of quorum sensing. |
BN, EMOC, MP |
| 89 |
2020 |
Effects of epigallocatechin gallate, epigallocatechin and epicatechin gallate on the chemical and cell-based antioxidant activity, sensory properties, and cytotoxicity of a catechin-free model beverage. |
ECG, EGC, OPC |
| 90 |
2020 |
Effects of green tea epigallocatechin-3-gallate on transcription factors regulating expression of FLT3. |
HOXA9, MEIS1 |
| 91 |
2020 |
Effects of oral administration of common antioxidant supplements on the energy metabolism of red blood cells. Attenuation of oxidative stress-induced changes in Rett syndrome erythrocytes by CoQ10. |
CoQ10, MDA, ORAC, RBC, RTT |
| 92 |
2020 |
Effects of Propolis and Phenolic Acids on Triple-Negative Breast Cancer Cell Lines: Potential Involvement of Epigenetic Mechanisms. |
DNMTi, EEP, epi-drugs, SAH |
| 93 |
2020 |
Effects of Standardized Green Tea Extract and Its Main Component, EGCG, on Mitochondrial Function and Contractile Performance of Healthy Rat Cardiomyocytes. |
GTE, PLB |
| 94 |
2020 |
Effects of Timing of Acute and Consecutive Catechin Ingestion on Postprandial Glucose Metabolism in Mice and Humans. |
--- |
| 95 |
2020 |
Efficacy of green tea and its extract, epigallocatechin-3-gallate, in the reduction of cariogenic microbiota in children: a randomized clinical trial. |
CFU |
| 96 |
2020 |
Efficacy of green tea, its polyphenols and nanoformulation in experimental colitis and the role of non-canonical and canonical nuclear factor kappa beta (NF-kB) pathway: a preclinical in-vivo and in-silico exploratory study. |
EC, ECG, EGC, NF-kB, TNBS |
| 97 |
2020 |
Efficacy of topical epigallocatechin gallate (EGCG) 1% on the healing of chronic plantar ulcers in leprosy. |
CPUL, FGD |
| 98 |
2020 |
EGCG ameliorates neuronal and behavioral defects by remodeling gut microbiota and TotM expression in Drosophila models of Parkinson's disease. |
PD, PINK1 |
| 99 |
2020 |
EGCG Attenuates Renal Damage via Reversing Klotho Hypermethylation in Diabetic db/db Mice and HK-2 Cells. |
alpha-SMA, CAT, DNMT1, IL-1beta, MDA, ROS, SOD, TGF-beta1, TNF-alpha |
| 100 |
2020 |
EGCG down-regulates MuRF1 expression through 67-kDa laminin receptor and the receptor signaling is amplified by eriodictyol. |
MuRF1 |
|
A Search Service for Abbreviation / Long Form
